• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BAXTER HEALTHCARE CORPORATION PRISMAFLEX TPE; SEPARATOR FOR THERAPEUTIC PURPOSES, MEMBRANE AUTOMATED BLOOD CELL/PLASMA

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BAXTER HEALTHCARE CORPORATION PRISMAFLEX TPE; SEPARATOR FOR THERAPEUTIC PURPOSES, MEMBRANE AUTOMATED BLOOD CELL/PLASMA Back to Search Results
Catalog Number 114093
Device Problem Complete Blockage (1094)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 11/29/2019
Event Type  malfunction  
Manufacturer Narrative
Should additional relevant information become available, a supplemental report will be submitted.
 
Event Description
It was reported that after starting therapeutic plasma exchange (tpe) treatment using four prismaflex tpe sets, clotting siting ¿access issues¿ was observed.It was reported that access was intact and patent.It was reported treatment was started with -50 to -80 and after five to ten minutes, the access would jump to over -250.Treatment was discontinued, and the extracorporeal (ec) blood was returned to the patient after the first event; however, it was unknown if the ec blood was returned for the subsequent events.It was reported a new tpe2000 was prepared; however, the event occurred again with "one to two filter sets".A tpe2000 set with a different lot number was then prepared and treatment was successfully completed.There was no report of patient injury or medical intervention associated with this event.No additional information is available.
 
Manufacturer Narrative
A batch review was conducted and there were no deviations found related to this reported condition during the manufacture of this lot.The device was not received for evaluation; therefore, a device analysis could not be completed.Should additional relevant information become available, a supplemental report will be submitted.
 
Manufacturer Narrative
Correction: removal of information in section f related to importer - the initial report inadvertently included the importer report number.This mdr should have been submitted only with the mfr.Number (and not as importer).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PRISMAFLEX TPE
Type of Device
SEPARATOR FOR THERAPEUTIC PURPOSES, MEMBRANE AUTOMATED BLOOD CELL/PLASMA
Manufacturer (Section D)
BAXTER HEALTHCARE CORPORATION
deerfield IL
MDR Report Key9507114
MDR Text Key193938558
Report Number8010182-2019-00219
Device Sequence Number1
Product Code MDP
UDI-Device Identifier07332414111038
UDI-Public07332414111038
Combination Product (y/n)N
PMA/PMN Number
P830063
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Type of Report Initial,Followup,Followup
Report Date 12/20/2019,12/18/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/20/2019
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date01/01/2022
Device Catalogue Number114093
Device Lot Number19A1504
Was Device Available for Evaluation? No
Was the Report Sent to FDA? Yes
Date Report Sent to FDA12/20/2019
Distributor Facility Aware Date11/29/2019
Event Location Hospital
Date Report to Manufacturer12/20/2019
Date Manufacturer Received12/17/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
ALBUMIN; CITRATE; PRISMAFLEX MACHINE; TRIALYSIS CATHETER 12 FRENCH15CM
-
-